Shoshana Shendelman is President and CEO of Applied Therapeutics Inc.. Currently has a direct ownership of 4.69 Million shares of APLT, which is worth approximately $43.2 Million. The most recent transaction as insider was on Aug 14, 2024, when has been sold 119,591 shares (Common Stock) at a price of $5.93 per share, resulting in proceeds of $709,174. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.69M
0% 3M change
80.39% 12M change
Total Value Held $43.2 Million

Shoshana Shendelman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 14 2024
SELL
Open market or private sale
$709,174 $5.93 p/Share
119,591 Reduced 2.49%
4,690,839 Common Stock
Aug 13 2024
SELL
Open market or private sale
$2,208,874 $6.18 p/Share
357,423 Reduced 6.92%
4,810,430 Common Stock
Aug 12 2024
SELL
Open market or private sale
$1,794,000 $5.98 p/Share
300,000 Reduced 5.49%
5,167,853 Common Stock
Jun 06 2024
SELL
Open market or private sale
$266,954 $4.32 p/Share
61,795 Reduced 1.62%
3,756,019 Common Stock
Mar 14 2024
SELL
Open market or private sale
$1,717,108 $5.39 p/Share
318,573 Reduced 7.7%
3,817,814 Common Stock
Dec 21 2023
BUY
Grant, award, or other acquisition
-
1,540,000 Added 27.13%
4,136,387 Common Stock
Nov 30 2023
SELL
Open market or private sale
$7,816 $1.97 p/Share
3,968 Reduced 0.15%
2,596,387 Common Stock
Sep 27 2023
SELL
Open market or private sale
$312,206 $2.7 p/Share
115,632 Reduced 4.26%
2,600,355 Common Stock
Jan 11 2023
SELL
Open market or private sale
$14,441 $0.91 p/Share
15,870 Reduced 2.07%
751,625 Common Stock
Jan 11 2023
BUY
Grant, award, or other acquisition
-
1,964,362 Added 41.97%
2,715,987 Common Stock
Oct 14 2022
BUY
Open market or private purchase
$32,000 $0.64 p/Share
50,000 Added 6.12%
767,495 Common Stock
Oct 13 2022
BUY
Open market or private purchase
$41,023 $0.56 p/Share
73,256 Added 9.26%
717,495 Common Stock
Oct 12 2022
BUY
Open market or private purchase
$19,840 $0.52 p/Share
38,153 Added 5.59%
644,239 Common Stock
Jan 07 2022
BUY
Grant, award, or other acquisition
-
120,900 Added 16.63%
606,086 Common Stock
Dec 14 2021
BUY
Grant, award, or other acquisition
-
120,900 Added 19.95%
485,186 Common Stock
Sep 14 2021
BUY
Open market or private purchase
$134,757 $14.49 p/Share
9,300 Added 2.49%
364,286 Common Stock
Sep 13 2021
BUY
Open market or private purchase
$10,298 $14.69 p/Share
701 Added 0.2%
354,986 Common Stock
SS

Shoshana Shendelman

President and CEO
New York, NY

Track Institutional and Insider Activities on APLT

Follow Applied Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APLT shares.

Notify only if

Insider Trading

Get notified when an Applied Therapeutics Inc. insider buys or sells APLT shares.

Notify only if

News

Receive news related to Applied Therapeutics Inc.

Track Activities on APLT